BridgeBio Pharma Inc logo

BBIO - BridgeBio Pharma Inc News Story

$52.94 -1.1  -2.0%

Last Trade - 05/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £5.81bn
Enterprise Value £5.75bn
Revenue £5.94m
Position in Universe 1066th / 6846

BRIEF-BridgeBio Pharma And The Lundquist Institute Collaborate To Advance Treatments For Genetically Driven Conditions And Cancers

Tue 13th April, 2021 3:01pm
April 13 (Reuters) - BridgeBio Pharma Inc  BBIO.O :
    * BRIDGEBIO PHARMA, INC. AND THE LUNDQUIST INSTITUTE
COLLABORATE
TO ADVANCE TREATMENTS FOR GENETICALLY DRIVEN CONDITIONS AND
CANCERS
    * BRIDGEBIO PHARMA INC - WILL POTENTIALLY SPONSOR RESEARCH
PROGRAMS AND SUPPORT DEVELOPMENT OF LUNDQUIST PROGRAMS AND
CLINICAL INVESTIGATIONS

Source text for Eikon:  ID:nGNX577V6Q 
Further company coverage:  BBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.